Official 2024 U.S. DOL Form 5500 summary for Hikma Pharmaceuticals USA INC. (Hikma Pharmaceuticals USA INC. 401(k) Retirement Plan · EIN 22-3114571 · PN 002): $274.80M net assets, 2,237 active participants, and $9.50 per $10,000 (9.50 bps).
| Plan Sponsor | Hikma Pharmaceuticals USA INC. |
|---|---|
| Filing Identifier | Hikma Pharmaceuticals USA INC. 401(k) Retirement Plan · EIN 22-3114571 · PN 002 |
| Plan Category & State | 401(k) Defined Contribution (NJ) |
| Asset-Size Peer Cohort | $100M-$500M |
| Plan Net Assets (2024) | $274.80M |
| Active Participants | 2,237 |
| Direct Admin Fee Rate | $9.50 per $10,000 (9.50 bps) |
| Cohort Peer Median | $9.75 per $10,000 (9.75 bps) |
| Primary Recordkeeper / Provider | Bank of America / Merrill |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($1.15M, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI
Verified federal filings reconciled for Hikma Pharmaceuticals across sibling Meru AI platforms.